Literature DB >> 8117579

Evaluation of human consciousness level by means of "Automated Fluctuation Analysis" of high frequency electroencephalogram fitted by double Lorentzians.

M Nakata1, J Mukawa, G H Fromm.   

Abstract

Since Berger's discovery of the electroencephalogram (EEG), its analysis has been generally restricted to the visual range (upmost 100Hz) and has ignored higher frequency components. One reason should be that there are no reliable methods to distinguish the brain potentials from muscle activity. We have introduced fluctuation analysis, which is popular method especially in the field of basic physiology to clinical electrophysiology. In our previous study, it was declared that power spectral density (PSD) of human high frequency EEG was composed of double Lorentzians and vanished into white level within 1kHz. Then the purpose of this study is to elucidate the "Automated Fluctuation Analysis," which enables us to evaluate these higher frequency components and its physiological meaning especially focused on conscious level from wakefulness to sleep stage 1. Seventy-four scalp recording EEGs in twenty normal subjects were studied. In short, "Automated Fluctuation Analysis" is made of three steps: amplification of EEG signal, A/D conversion and Fast Fourier Transform by signal processor and extraction of Lorentzian parameters. PSD of high frequency EEG was displayed on log-log graph and the algorithm fit to the following Lorentzian formula were mathematically based on Brown & Dennis. S(f) = S1/[1+(f/fc1)2]+S2/[1+(f/fc2)2], where S(f) is PSD (mu V2/Hz) at each frequency (f;Hz), S1 and S2 are the plateau level or zero-frequency power of the initial and second Lorentz, and fc1 and fc2 are the corner or half-power frequency of the initial and second Lorentz, respectively. As results, during wakefulness the PSD of high frequency EEG activity was composed of double Lorentzian fluctuations and the power distribution of S1 value in topographical display was frontal dominant. This pattern of S1 value disappeared and S2 value became lower during sleepiness and the second Lorentz disappeared during sleep.

Entities:  

Mesh:

Year:  1993        PMID: 8117579     DOI: 10.1007/bf02690931

Source DB:  PubMed          Journal:  Integr Physiol Behav Sci        ISSN: 1053-881X


  8 in total

1.  Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors:  T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal:  Psychiatry Clin Neurosci       Date:  2001-06       Impact factor: 5.188

2.  Pharmacologic dissociation of behavior and EEG "sleep patterns" in dogs; morphine, n-allylnormorphine, and atropine.

Authors:  A WIKLER
Journal:  Proc Soc Exp Biol Med       Date:  1952-02

3.  Fourier analysis of broad spectral EEG from a fluctuation point of view.

Authors:  M Nakata; K Mukawa
Journal:  Pavlov J Biol Sci       Date:  1989 Jul-Sep

Review 4.  The EEG and awareness during anaesthesia.

Authors:  K Mori
Journal:  Anaesthesia       Date:  1987-11       Impact factor: 6.955

5.  "Hyperfrontal" distribution of the cerebral grey matter flow in resting wakefulness; on the functional anatomy of the conscious state.

Authors:  D H Ingvar
Journal:  Acta Neurol Scand       Date:  1979-07       Impact factor: 3.209

6.  Changes in hyperfrontality of cerebral blood flow and carbon dioxide reactivity with age.

Authors:  Y Tsuda; A Hartmann
Journal:  Stroke       Date:  1989-12       Impact factor: 7.914

7.  Ion channels activated by L-glutamate and GABA in cultured cerebellar neurons of the rat.

Authors:  S G Cull-Candy; D C Ogden
Journal:  Proc R Soc Lond B Biol Sci       Date:  1985-05-22

8.  [Electrophysiological evaluation of human consciousness level by "Automated Fluctuation Analysis" of human high frequency EEG].

Authors:  M Nakata; J Mukawa; K Nerome; S Hokama
Journal:  No To Shinkei       Date:  1992-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.